Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 4/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | PRF1 | P14222 | 3/20 | 0.30 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10001802 | 0.92 | NQO2 (0.33) | HSD17B1HSD17B2PRKDCNQO2 | |
| SCHEMBL12156773 | 0.88 | — | — | |
| SCHEMBL12700853 | 0.78 | HSD17B1 (0.57) | HSD17B1HSD17B2NQO2 | |
| SCHEMBL10071935 | 0.76 | ALOX5 (0.41) | PRKDC | |
| SCHEMBL14505902 | 0.76 | HSD17B1 (0.55) | HSD17B1HSD17B2NQO2 | |
| SCHEMBL26173111 | 0.75 | CA12 (0.34) | HSD17B1HSD17B2 | |
| SCHEMBL14505908 | 0.74 | HSD17B1 (0.53) | HSD17B1HSD17B2NQO2 | |
| SCHEMBL10001805 | 0.73 | CYP11B2 (0.43) | — | |
| SCHEMBL12700835 | 0.73 | HSD17B1 (0.45) | HSD17B1HSD17B2PRKDCNQO2 | |
| SCHEMBL27271838 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150536-B2 | Cycloalkene derivatives and organic electronic devices using the same | LG CHEM, LTD. (KR) | 2015-10-06 | — | — | US | disclosed |
| US-9150536-B2 | Cycloalkene derivatives and organic electronic devices using the same | LG CHEM, LTD. (KR) | 2015-10-06 | — | — | US | disclosed |
| US-20120037892-A1 | NOVEL CYCLOALKENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICES USING THE SAME | LG CHEM, LTD. (KR) | 2012-02-16 | — | — | US | disclosed |
| US-20120037892-A1 | NOVEL CYCLOALKENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICES USING THE SAME | LG CHEM, LTD. (KR) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120037892-A1 | NOVEL CYCLOALKENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICES USING THE SAME | DDT, ICMT, ESD | HSD17B1 751/4885HSD17B2 578/4885PRKDC 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.